Detection of toxigenic strains of clostridium difficile

Details for Australian Patent Application No. 2008295396 (hide)

Owner Geneohm Sciences Canada, Inc.

Inventors Paquette, Nancy; Rochette, Marie-Eve; Labourdette, Rachel

Agent Davies Collison Cave

Pub. Number AU-A-2008295396

PCT Pub. Number WO2009/030031

Priority 60/970,492 06.09.07 US

Filing date 5 September 2008

Wipo publication date 12 March 2009

International Classifications

C12N 15/31 (2006.01) Mutation or genetic engineering - Genes encoding microbial proteins, e.g. enterotoxins

C07H 21/00 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07H 21/04 (2006.01) Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

C07K 14/33 (2006.01) Peptides having more than 20 amino acids

C12P 19/34 (2006.01) Preparation of compounds containing saccharide radicals

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

8 April 2010 PCT application entered the National Phase

  PCT publication WO2009/030031 Priority application(s): WO2009/030031

13 May 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 12 Apr 2010

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008295417-Drill bit

2008295394-Method of using tumour RNA integrity to measure response to chemotherapy in cancer patients